当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kenji Takahashi
Hypertensive nephropathy is a common cause of chronic kidney disease and end-stage renal disease worldwide.However, the molecular mechanisms underlying this condition remain poorly understood. Proteomic analysis hasemerged as a powerful tool to investigate complex protein networks in various diseases, including renal disorders.Archival core human kidney biopsies, obtained from patients with a documented history of hypertension and renalimpairment, offer a unique opportunity to study the proteomic patterns associated with hypertensive nephropathy.By employing advanced proteomic techniques, researchers can analyze the proteome of these biopsies and identify differentially expressed proteins and pathways related to the disease. This article provides insights into the potential of proteomic analysis in hypertensive nephropathy, including the identification of biomarkers for early diagnosis andmonitoring, and the elucidation of molecular pathways involved in disease progression. Despite challenges associatedwith limited sample availability and protein degradation over time, advancements in proteomic technologies andbioinformatics tools hold great promise for further understanding and managing hypertensive nephropathy.